Pancreatic Cancer Research

ResearcherNational Medical Products AdministrationActive in the last 2 years

Hua Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4769-3564; OpenAlex author ID A5023342494. Sources: ClinicalTrials.gov.

Their work

Papers
4
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper, 1 trial · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Construction of Bispecific T-Cell Engager Radiotracer and Its Micro-PET Evaluation in Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.5c00072↗
  2. KRAS Mutation Detection with (2S,4R)-4-[18F]FGln for Noninvasive PDAC Diagnosis. Co-author DOI 10.1021/acs.molpharmaceut.4c00082↗
  3. Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR. Co-author DOI 10.3389/fonc.2021.790462↗
  4. Clinical Translation of a 68Ga-Labeled Integrin αvβ6-Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer. Co-author DOI 10.2967/jnumed.119.237347↗

Trials 1

  1. PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor Principal investigator NCT05156515↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhi Yang · 2 shared papers, 2024–2025 · strength 0.46
  2. Xiaoxia Xu · 2 shared papers, 2020–2024 · strength 0.33
  3. Hao Zhang · 1 shared paper, 2025 · strength 0.23
  4. Dan Wen Wen · 1 shared paper, 2025 · strength 0.23
  5. Song Liu · 1 shared paper, 2024 · strength 0.23
  6. Zhi‐gang Yang · 1 shared paper, 2021 · strength 0.16
  7. Z Zhang · 1 shared paper, 2021 · strength 0.16
  8. Zhaofei Liu · 1 shared paper, 2020 · strength 0.10
  9. Xun Feng · 1 shared paper, 2020 · strength 0.10
  10. Fan Wang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.